PRL and schizophrenia: The selection of antipsychotics (prolactin raising vs. prolactin sparing; weight gaining vs. weight sparing) for the treatment of postmenopausal women with schizophrenia and related disorders is one of the major challenges in gender approaches to treatment and remains unresolved due to the lack of randomized-controlled trials.